Abiopharma

🔍 MCCONNELL RICK M (Director)

Company: Dynatrace, Inc. (DT)

Report Date: 2026-06-05

Detailed Transactions and Holdings:

• Acquired 17,145 shares of Common Stock (Direct)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 186,845.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 8,724 shares of Common Stock at $42.19 per share (Direct)
  Date: 2026-06-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 178,121.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 12,607 shares of Common Stock (Direct)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 190,728.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 6,415 shares of Common Stock at $42.19 per share (Direct)
  Date: 2026-06-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 184,313.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 11,554 shares of Common Stock (Direct)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 195,867.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 5,879 shares of Common Stock at $42.19 per share (Direct)
  Date: 2026-06-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 189,988.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 14,814 shares of Common Stock (Direct)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 204,802.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 7,538 shares of Common Stock at $42.19 per share (Direct)
  Date: 2026-06-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 197,264.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 14,504 shares of Common Stock (Direct)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 211,768.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 7,380 shares of Common Stock at $42.19 per share (Direct)
  Date: 2026-06-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 204,388.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 53,383 shares of Common Stock (Direct)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 257,771.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 27,162 shares of Common Stock at $42.19 per share (Direct)
  Date: 2026-06-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 230,609.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 36,515 shares of Common Stock (Direct)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 267,124.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 18,579 shares of Common Stock at $42.19 per share (Direct)
  Date: 2026-06-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 248,545.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-05 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 500.00 | Footnotes: F3
• Sold 17,145 shares of Performance Restricted Stock Units (Financial) (Derivative)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4, F1
• Sold 12,607 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F5, F1
• Sold 11,554 shares of Performance Restricted Stock Units (Financial) (Derivative)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 46,218.00 | transaction_form_type: 4 | Footnotes: F1, F6, F1
• Sold 14,814 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 59,257.00 | transaction_form_type: 4 | Footnotes: F1, F7, F1
• Sold 14,504 shares of Performance Restricted Stock Units (rTSR) (Derivative)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F8, F1
• Sold 53,383 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 108,382.00 | transaction_form_type: 4 | Footnotes: F1, F9, F1
• Sold 36,515 shares of Performance Restricted Stock Units (Financial) (Derivative)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 60,544.00 | transaction_form_type: 4 | Footnotes: F1, F10, F1
• Acquired 177,768 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 177,768.00 | transaction_form_type: 4 | Footnotes: F1, F11, F1

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units do not expire. They either vest or are cancelled prior to the vesting date.
• F2: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations upon the vesting of restricted stock units.
• F3: Shares held by the Anne Marie McConnell Trust dated July 16, 2021, for which the Reporting Person's spouse is the sole trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares except to the extent of his pecuniary interest, if any, therein, and nothing contained in this report shall be deemed an admission that the Reporting Person is the beneficial owner of any of the shares for Section 16 purposes or otherwise.
• F4: Represents the vesting of restricted stock units based on financial performance ("Financial PSUs") granted on June 5, 2023 under the Issuer's 2019 Equity Incentive Plan, as amended (the "Plan"). 33% of the Financial PSUs granted vested on June 5, 2024 and the balance of the Financial PSUs vested in equal quarterly installments thereafter until fully vested on June 5, 2026.
• F5: Represents the vesting of time-based restricted stock units ("RSUs") granted on June 5, 2023 under the Plan. 33% of the RSUs granted vested on June 5, 2024 and the balance of the RSUs vested in equal quarterly installments thereafter until fully vested on June 5, 2026.
• F6: Represents the vesting of Financial PSUs granted on June 5, 2024 under the Plan. 33% of the Financial PSUs granted vested on June 5, 2025 and the balance of the Financial PSUs vest in equal quarterly installments thereafter until fully vested on June 5, 2027, subject to the Reporting Person's continued employment on the applicable vesting dates.
• F7: Represents the vesting of RSUs granted on June 5, 2024 under the Plan. 33% of the RSUs granted vested on June 5, 2025 and the balance of the RSUs vest in equal quarterly installments thereafter until fully vested on June 5, 2027, subject to the Reporting Person's continued employment on the applicable vesting dates.
• F8: Represents the vesting of restricted stock units based on relative total stockholder return ("rTSR PSUs") granted on June 5, 2024 under the Plan. These rTSR PSUs were earned following certification by the Compensation Committee of the Board of Directors of the Issuer (the "Compensation Committee") of certain performance conditions related to relative total stockholder return for the two year performance period that started on April 1, 2024 and ended on March 31, 2026. All of these rTSR PSUs vested on June 5, 2026.
• F9: Represents the vesting of RSUs granted on June 5, 2025 under the Plan. 33% of the RSUs vested on June 5, 2026 and the balance of the RSUs vest in equal quarterly installments thereafter until fully vested on June 5, 2028, subject to the Reporting Person's continued employment on the applicable vesting dates.
• F10: Represents the vesting of Financial PSUs granted on June 5, 2025 under the Plan and earned following certification by the Compensation Committee of certain financial performance results for the Issuer's fiscal year 2026 that started on April 1, 2025 and ended on March 31, 2026. 33% of the Financial PSUs vested on June 5, 2026, and the balance of the Financial PSUs vest in equal quarterly installments thereafter until fully vested on June 5, 2028, subject to the Reporting Person's continued employment on the applicable vesting dates.
• F11: Represents the grant of RSUs under the Plan. 33% of these RSUs will vest on June 5, 2027 and the balance of the RSUs will vest in equal quarterly installments thereafter until fully vested on June 5, 2029, subject to the Reporting Person's continued employment on the applicable vesting dates.